Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Statements of Stockholders' Equity

v3.25.1
Consolidated Statements of Stockholders' Equity - USD ($)
Total
Common Stock 0.001 Par Value
Additional Paid-in Capital
Accumulated Deficit
Noncontrolling Interest
Beginning balance, shares at Dec. 31, 2022   24,850,261      
Balance, beginning balance at Dec. 31, 2022 $ 18,987,750 $ 24,850 $ 57,351,008 $ (38,281,548) $ (106,560)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Distributions to noncontrolling interest (62,693)       (62,693)
Stock-based compensation 250,394   250,394    
Net income (loss) (4,523,156)     (4,598,108) 74,952
Ending balance, shares at Dec. 31, 2023   24,850,261      
Balance, ending balance at Dec. 31, 2023 14,652,295 $ 24,850 57,601,402 (42,879,656) (94,301)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares)   100,000      
Exercise of stock options 71,000 $ 100 70,900    
Distributions to noncontrolling interest (96,974)       (96,974)
Stock-based compensation 172,987   172,987    
Net income (loss) (4,673,770)     (4,760,238) 86,468
Ending balance, shares at Dec. 31, 2024   24,950,261      
Balance, ending balance at Dec. 31, 2024 $ 10,125,538 $ 24,950 $ 57,845,289 $ (47,639,894) $ (104,807)